Evaluation of NSD2 and NSD3 in overgrowth syndromes

被引:27
作者
Douglas, J
Coleman, K
Tatton-Brown, K
Hughes, HE
Temple, IK
Cole, TRP
Rahman, N
机构
[1] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England
[2] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales
[3] Southampton Univ Hosp, Dept Human Genet, Southampton, Hants, England
[4] Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England
关键词
Sotos syndrome; overgrowth syndromes; NSD1; NSD2; NSD3;
D O I
10.1038/sj.ejhg.5201298
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sotos syndrome is an overgrowth condition predominantly caused by truncating mutations, missense mutations restricted to functional domains, or deletions of NSD1. NSD1 is a member of a protein family that includes NSD2 and NSD3, both of which show 70-75% sequence identity with NSD1. This strong sequence similarity suggests that abrogation of NSD2 or NSD3 function may cause non-NSD1 Sotos cases or other overgrowth phenotypes. To evaluate this hypothesis, we mutationally screened NSD2 and NSD3 in 78 overgrowth syndrome cases in which NSD1 mutations and deletions had been excluded. Additionally, we used microsatellite markers within the vicinity of the genes to look for whole gene deletions. No truncating mutations or gene deletions were identified in either gene. We identified two conservative missense NSD2 alterations in two non-Sotos overgrowth cases but neither was within a functional domain. We identified three synonymous and two intronic variants in NSD2 and two synonymous base substitutions in NSD3. Our results suggest that despite strong sequence similarity between NSD1, NSD2 and NSD3, the latter genes are unlikely to be making a substantial contribution to overgrowth phenotypes and thus may operate in distinct functional pathways from NSD1.
引用
收藏
页码:150 / 153
页数:4
相关论文
共 15 条
[1]   NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines [J].
Angrand, PO ;
Apiou, F ;
Stewart, AF ;
Dutrillaux, B ;
Losson, R ;
Chambon, P .
GENOMICS, 2001, 74 (01) :79-88
[2]   Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia [J].
Cerveira, N ;
Correia, C ;
Dória, S ;
Bizarro, S ;
Rocha, P ;
Gomes, P ;
Torres, L ;
Norton, L ;
Borges, BS ;
Castedo, S ;
Teixeira, MR .
LEUKEMIA, 2003, 17 (11) :2244-2247
[3]   SOTOS SYNDROME - A STUDY OF THE DIAGNOSTIC-CRITERIA AND NATURAL-HISTORY [J].
COLE, TRP ;
HUGHES, HE .
JOURNAL OF MEDICAL GENETICS, 1994, 31 (01) :20-32
[4]   NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of weaver syndrome but are rare in other overgrowth phenotypes [J].
Douglas, J ;
Hanks, S ;
Temple, IK ;
Davies, S ;
Murray, A ;
Upadhyaya, M ;
Tomkins, S ;
Hughes, HE ;
Cole, TRP ;
Rahman, N .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (01) :132-143
[5]   An update on conformation sensitive gel electrophoresis [J].
Ganguly, A .
HUMAN MUTATION, 2002, 19 (04) :334-342
[6]   Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators [J].
Huang, NW ;
vom Baur, E ;
Garnier, JM ;
Lerouge, T ;
Vonesch, JL ;
Lutz, Y ;
Chambon, P ;
Losson, R .
EMBO JOURNAL, 1998, 17 (12) :3398-3412
[7]   Sotos syndrome and haploinsufficiency of NSD1:: clinical features of intragenic mutations and submicroscopic deletions [J].
Nagai, T ;
Matsumoto, N ;
Kurotaki, N ;
Harada, N ;
Niikawa, N ;
Ogata, T ;
Imaizumi, K ;
Kurosawa, K ;
Kondoh, T ;
Ohashi, H ;
Tsukahara, M ;
Makita, Y ;
Sugimoto, T ;
Sonoda, T ;
Yokoyama, T ;
Uetake, K ;
Sakazume, S ;
Fukushima, Y ;
Naritomi, K .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (04) :285-289
[8]   Translocations involving 4p16.3 in three families: deletion causing the Pitt-Rogers-Danks syndrome and duplication resulting in a new overgrowth syndrome [J].
Partington, MW ;
Fagan, K ;
Soubjaki, V ;
Turner, G .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (09) :719-728
[9]   NSD1 is essential for early post-implantation development and has a catalytically active SET domain [J].
Rayasam, GV ;
Wendling, O ;
Angrand, PO ;
Mark, M ;
Niederreither, K ;
Song, L ;
Lerouge, T ;
Hager, GL ;
Chambon, P ;
Losson, R .
EMBO JOURNAL, 2003, 22 (12) :3153-3163
[10]   Mitotic-specific methylation of histone H4 Lys 20 follows increased PR-Set7 expression and its localization to mitotic chromosomes [J].
Rice, JC ;
Nishioka, K ;
Sarma, K ;
Steward, R ;
Reinberg, D ;
Allis, CD .
GENES & DEVELOPMENT, 2002, 16 (17) :2225-2230